The role of surgery in recurrent ovarian cancer (ROC) is debated. Multiple prospective and retrospective series reported improved survival with optimal secondary surgical cytoreduction, but definitive results from randomized trials are needed. Up to the fourth cytoreductive surgery for recurrent disease in an attempt to improve patients' prognosis has been reported.
Beyond the beyond: first case of 9 cytoreductive surgeries in a long-surviving ovarian cancer patient: case report / Salerno, Laura; Marchetti, Claudia; Bevilacqua, Elisa; Musella, Angela; Riganelli, Lucia; Ruscito, Ilary; Perniola, Giorgia; Muzii, Ludovico; BENEDETTI PANICI, Pierluigi. - In: TUMORI. - ISSN 0300-8916. - STAMPA. - 102:Suppl 2(2016), pp. 78-81. [10.5301/tj.5000427]
Beyond the beyond: first case of 9 cytoreductive surgeries in a long-surviving ovarian cancer patient: case report
SALERNO, LAURA
;MARCHETTI, CLAUDIA;BEVILACQUA, ELISA;MUSELLA, ANGELA;RIGANELLI, LUCIA;RUSCITO, ILARY;PERNIOLA, GIORGIA;MUZII, LUDOVICO;BENEDETTI PANICI, PIERLUIGI
2016
Abstract
The role of surgery in recurrent ovarian cancer (ROC) is debated. Multiple prospective and retrospective series reported improved survival with optimal secondary surgical cytoreduction, but definitive results from randomized trials are needed. Up to the fourth cytoreductive surgery for recurrent disease in an attempt to improve patients' prognosis has been reported.| File | Dimensione | Formato | |
|---|---|---|---|
|
Salerno_cytoreductive-surgeries_2016.pdf
solo gestori archivio
Tipologia:
Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza:
Tutti i diritti riservati (All rights reserved)
Dimensione
554.47 kB
Formato
Adobe PDF
|
554.47 kB | Adobe PDF | Contatta l'autore |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
